Francesca Terracciani

Author's reply: "Beyond a single metric: A stratified algorithm for non-invasive risk assessment in MASLD".

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 09, 2026

Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLD.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: July 14, 2025

Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 09, 2025

Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study.

Journal: Viruses

Published: December 19, 2024

Biopsy in chronic liver disease: proposal for a shared path between clinicians and pathologists.

Journal: Pathologica

Published: July 30, 2024

Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.

Journal: JHEP reports : innovation in hepatology

Published: July 30, 2024

Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study.

Journal: Journal of clinical medicine

Published: May 21, 2024

Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 05, 2024

Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.

Journal: Diabetes/metabolism research and reviews

Published: December 05, 2023

Author's reply: "Beyond a single metric: A stratified algorithm for non-invasive risk assessment in MASLD".

Author's reply: "Beyond a single metric: A stratified algorithm for non-invasive risk assessment in MASLD".

Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLD.

Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLD.

Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study.

Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study.

Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study.

Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study.

Biopsy in chronic liver disease: proposal for a shared path between clinicians and pathologists.

Biopsy in chronic liver disease: proposal for a shared path between clinicians and pathologists.

Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.

Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.

Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study.

Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study.

Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis.

Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis.

Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.

Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.

Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis.

Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis.

Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population.

Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population.

Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers.

Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers.